
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
AKAP 79 CRISPR/Cas9 KO Plasmid (h) | sc-402647 | 20 µg | $397.00 |
AKAP5 encodes AKAP 79, a membrane-associated A-kinase anchoring protein that organizes multiprotein signaling complexes by tethering PKA alongside phosphatases such as calcineurin and PP2B to defined subcellular microdomains. By scaffolding kinases, phosphatases, and receptors, AKAP 79 shapes signal amplitude and duration in pathways controlling synaptic plasticity, receptor trafficking, and activity-dependent phosphorylation, including calcium- and cAMP-regulated processes. In neurons and excitable tissues, this spatial regulation influences ion channel modulation and downstream transcriptional responses. Dysregulated AKAP 79 signaling has been implicated in altered neuronal excitability and network function, making AKAP5 a useful node for studying mechanisms relevant to neurological disease biology and stress-responsive signaling.
AKAP 79 CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the AKAP5 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the AKAP5 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the AKAP5 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish AKAP 79 protein expression.
This CRISPR knockout system enables efficient generation of AKAP5-deficient cell models for investigation of AKAP 79 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.